Green Cross Holdings Corporation operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Green Cross Holdings with three other
pharmaceutical manufacturers in Asia:
Kissei Pharmaceutical Company Limited
sales of 70.11 billion Japanese Yen [US$677.96 million]
of which 85%
was Pharmaceutical Products),
(1.13 trillion Korean Won [US$1.01 billion]
of which 100%
was Pharmaceuticals), and
China Resources Double-Crane Pharmaceutical Company Limited
based in China
(5.14 billion Chinese Renmimbi [US$762.30 million]
of which 52%
Green Cross Holdings reported sales of 1.13 trillion Korean Won (US$1.01 billion)
December of 2015.
increase of 8.5%
versus 2014, when the company's sales were 1.04 trillion Korean Won.
This was the fourth straight year of sales growth at Green Cross Holdings.